key: cord-0730793-cg3532qm
authors: Lombardi, Fiorella Anna; Franchini, Roberto; Morello, Rocco; Casciaro, Ernesto; Ianniello, Stefania; Serra, Maurizio; Satriano, Francesco; Mojoli, Francesco; Mongodi, Silvia; Pignatelli, Daniela; Di Paola, Marco; Casciaro, Sergio
title: A new standard scoring for interstitial pneumonia based on quantitative analysis of ultrasonographic data: a study on COVID-19 patients
date: 2021-10-07
journal: Respir Med
DOI: 10.1016/j.rmed.2021.106644
sha: a0f8c2f9a8a3cdaaac8666fdf299bbafe02e43a7
doc_id: 730793
cord_uid: cg3532qm

OBJECTIVE: To assess the effectiveness of 3 novel lung ultrasound (LUS)-based parameters: Pneumonia Score and Lung Staging for pneumonia staging and COVID Index, indicating the probability of SARS-CoV-2 infection. METHODS: Adult patients admitted to the emergency department with symptoms potentially related to pneumonia, healthy volunteers and clinical cases from online accessible databases were evaluated. The patients underwent a clinical-epidemiological questionnaire and a LUS acquisition, following a 14-zone protocol. For each zone, a Pneumonia score from 0 to 4 was assigned by the algorithm and by an expert operator (kept blind with respect to the algorithm results) on the basis of the identified imaging signs and the patient Lung Staging was derived as the highest observed score. The output of the operator was considered as the ground truth. The algorithm calculated also the COVID Index by combining the automatically identified LUS markers with the questionnaire answers and compared with the nasopharyngeal swab results. RESULTS: Overall, 556 patients were analysed. A high agreement between the algorithm assignments and the expert operator evaluations was observed, both for Pneumonia Score and Lung Staging, with the latter having sensitivity and specificity over 92% both in the discrimination between healthy/sick patients and between sick patients with mild/severe pneumonia. Regarding the COVID Index, an area under the curve of 0.826 was observed for the classification of patients with/without SARS-CoV-2. CONCLUSION: The proposed methodology allowed the identification and staging of patients suffering from pneumonia with high accuracy. Moreover, it provided the probability of being infected by SARS-CoV-2.

considered as the ground truth. The algorithm calculated also the COVID Index by combining the 23 automatically identified LUS markers with the questionnaire answers and compared with the nasopharyngeal 24 swab results. 25

Results: Overall, 556 patients were analysed. A high agreement between the algorithm assignments and the 26 expert operator evaluations was observed, both for Pneumonia Score and Lung Staging, with the latter having 27 sensitivity and specificity over 92% both in the discrimination between healthy/sick patients and between 28 sick patients with mild/severe pneumonia. Regarding the COVID Index, an area under the curve of 0.826 was 29 observed for the classification of patients with/without SARS-CoV-2. and their evolution depending on the degree and extent of consolidation [1] . Indeed, it has been widely used 37 as a non-invasive bedside technique for identifying, diagnosing and following-up pneumonia and other 38 respiratory diseases [2] [3] [4] [5] [6] [7] . Although its capability to provide relevant diagnostic information on pulmonary 39 tissue has been investigated since the 1990s [8, 9] , the standardization of a procedure for the quantitative 40 scoring of disease severity is still debated [10] [11] [12] . 41

In 2020, the usefulness of LUS emerged during the pandemic caused by the severe acute respiratory 42 syndrome coronavirus 2 (SARS-CoV-2) [13, 14] . The improvement in sensitivity in the early identification of 43 effectiveness of a derived parameter (Lung Staging) in the total staging of pneumonia, again with respect to 69 an expert operator. As secondary objective, the performance of a further novel index (COVID Index), related 70 to the probability that the observed pneumonia was due to SARS-CoV-2 infection, was evaluated. The enrolment period lasted from April 15 th to May 31 st 2020. To reach the required sample size, as detailed 81 later in text, additional clinical cases were obtained from clinical databases freely accessible online, such as 82

Butterfly, Grepmed and ThePocusAtlas (available at butterflynetwork.com, grepmed.com and 83 thepocusatlas.com, respectively). 84

The resulting dataset was randomly split into two equal-sized sub-datasets, which were separately used: the 85 first to implement the algorithm with the clinical parameters described below (cf. "Outcome" paragraph) and 86 the second as an independent cohort to validate their performance. 87

The protocol was approved by the institutional review board. All patients provided an informed consent and 88 all data were immediately anonymized. The study was conducted in accordance with the principles of the 89 Declaration of Helsinki for clinical research involving human subjects. 90

The eligibility criteria for the inclusion in the study were: both women and men; all ethnicities; age >18 years; 92 healthy volunteers or subjects who referred to the point of care for triage because of one or more of the 93 following conditions: (i) Travel/residence history in the areas with a high rate of COVID-19 transmission; (ii) 94

Exposure to patients with fever or respiratory symptoms who were in the areas with a high rate of COVID- The recruited patients underwent a clinical and epidemiological questionnaire prior to the ultrasound  101   acquisition, outlined as an adaptation of the World Health Organization seroepidemiological investigation  102   protocol for COVID-19 infection [20] , in order to collect information about concomitant symptoms (i.e.: fever; 103 sore throat; respiratory symptoms including cough, difficulty in breathing and wheezing; loss or alteration of 104 smell and taste; diarrhea) and likelihood of exposure to SARS-CoV-2 (i.e.: travel or residence in a country with 105 local transmission in the 14 days prior to the onset of symptoms; close contact with probable or confirmed 106 cases in the 14 days prior to the onset of symptoms). 107

The device used to perform the LUS scan consisted of a battery based ultra-portable ultrasonographic unit 108 and a convex probe operating at the nominal frequency of 3.5 MHz. The Lung 19 software module integrated 109 in the device included a novel proprietary algorithm for the automatic recognition of the characteristic 110 patterns of pneumonia, whose working principle is detailed in the next paragraph. The LUS acquisition was 111 guided by the software, which had most of the presets pre-configured with locked values (e.g., tissue 112 harmonics off). The only unlocked parameters were depth, focus and gain: depth (ranging from 90 to 210 113 mm) was set according to the patient's BMI; focus was set as close as possible to the pleural line level; gain 114 value was selected by the operator to obtain the better visualization of the pleura and possible pneumonia 115 markers. In general, the locked preset values combined with the indicated setting of depth, focus and gain 116 resulted in a quick and effective acquisition procedure, also in presence of potentially challenging situations 117 (e.g., obese patients). A water-soluble and hypoallergenic coupling gel, e.g. Aquasonic® 100 Ultrasound Gel 118 (Parker Laboratories, Fairfield, NJ, USA), was used for the probe-skin coupling. The probe was suitably 119 preserved from contamination through the use of a latex probe cover. Moreover, the employed portable 120 ultrasound device was easily sanitized before and after each use with disinfectant wipes. 121

The LUS acquisition protocol was fully guided by a software interface and was based on the 14-zones method 122

[21], namely 7 zones per side (left and right). However, because one of the main scopes of the adopted 123 methodology is to perform a quick diagnosis, a minimum of four zones was considered sufficient in the triage 124 phase, although the acquisition of more zones was allowed and left to the clinician judgement. The location 125 and the minimum number of zones were selected according to recent studies already available in the 126 literature [22] . Each acquired zone was scanned with the probe in longitudinal and transversal direction, with 127 12 frames acquired per scan (thus, a total of 24 frames per zone were acquired). In detail, for each patient, 128 the following zones could be acquired: For each considered anatomical zone, each image is segmented through the following steps (applied to either 151 longitudinal and transversal acquisitions and illustrated in Figure 3a for the case of a transversal image): 152 1.

Preliminary image validation, based on grey level and geometrical feature analysis, in order to verify 153 the image suitability for the subsequent processing steps and to discard possible images of insufficient 154 quality. 155

Image pre-processing, consisting in grey level adjustment and image cutting and resizing ( Figure 3b ). 156

Search for 'raw' target structures (i.e., anatomical landmarks, echographic markers and signs), based 157 only on pixel cluster positions and their grey level intensity values, where the term 'raw' indicates that this 158 first attempt of marker segmentation may necessitate further refinements because the identified pixel 159 clusters could contain some imperfections due to background noise ( Figure 3c ). For each analysed zone, the Pneumonia Score, ranging from 0 to 4, was assigned by the algorithm on the 180 basis of the identified pneumonia signs (see also Figure 4 ). This score expressed the following disease grades: 181 "0" in case of no disease, with presence of A-lines and absence of vertical artefacts (Score 0 in Figure 4) ; "1" 182 in case of early stage of the disease, with less than 3 focal B-lines (Score 1 in Figure 4) ; "2" in case of 183 intermediate stage of disease, with diffused and multifocal B-lines (Score 2 in Figure 4) ; "3" in case of 184 advanced stage of the disease, with diffused and multifocal B-lines and initial subpleural consolidations and 185 white lung pattern (Score 3 in Figure 4) ; "4" in case of very severe stage of the disease, with diffuse and 186 multifocal B-lines and lung consolidations (Score 4 in Figure 4 ). Then, the Lung Staging was obtained as the 187 highest Pneumonia Score identified during the examination, and consequently it ranged from 0 to 4 as well. 188

This diagnostic parameter represented the overall staging of the disease as a global assessment of the lung 189 health status. Of note, the adopted software was thought and designed to give the operator the possibility 190 to correct the Pneumonia Score values assigned by the algorithm. However, this function was inhibited in the 191 device used for the present study, since the purpose was to validate the automatic algorithm with respect to 192 the scores assigned by the expert operator, employing a "double-blind" approach. For this reason, changes 193 to the automatically assigned scores were never made in any step of this study. 

Considering the independent validation dataset and assessing the performance of the algorithm in the 270 Pneumonia Score assignment, the Spearman correlation coefficient was ρ=0.932 (95% CI: 0.927 to 0.937, 271 p<0.0001), the χ 2 test was significant (contingency coefficient = 0.860, p<0.0001) and Cohen's K was 0.901 272 (95% CI: 0.887 to 0.914). The overall rate of agreement between the Pneumonia Score assigned by the expert 273 operator and the one assigned by the algorithm was 90.8%.

Lung Staging assigned by the automatic algorithm and the expert operator was ρ=0.916 (95% CI: 0.894 to 276 0.933, p<0.0001). At χ 2 test, a significant p-value was obtained (p<0.0001), with a contingency coefficient of 277 0.843, showing that there was a strong relationship between the evaluation performed by the automatic 278 algorithm and the expert operator. The distribution of classification among classes performed by the expert 279 operator and the software algorithm is shown in Figure 5 . The Cohen's K was 0.848 (95% CI: 0.808 to 0.888). 280

The percentage of overall agreement in the 5-grade classification was 80.6%, meaning that in large majority 281 of cases the diagnostic classification performed by the algorithm was in the same class as the one performed 282 by the operator. 283

As concerning the capability to classify patients into sick and healthy (i.e. Lung Staging = 0 and Lung Staging 284 > 0, respectively), the diagnostic agreement was 93.5%, the sensitivity was 94.4% and specificity was 90.3%. 285

The PPV and NPV were 97.1% and 82.4%, respectively. As concerning the capability to classify patients with 286 mild or severe signs, instead, (i.e. Lung Staging ≤ 2 and Lung Staging > 2, respectively), the diagnostic 287 agreement was 92.2%, the sensitivity was 92.0% and specificity was 92.8%, whereas the PPV and NPV were 288 96.1% and 85.3%, respectively. The extensive results about the performance obtained with the validation 289 dataset are reported in Tables 1-3 . Considering the prevalence of SARS-CoV-2 positivity compared to the average COVID index evaluated in steps 302 of 10 units, the correlation was very high, with r=0.977, r 2 =0.954 and the slope of the regression line 0.92 303 (95% CI: 0.75 to 1.08). The regression distribution is reported in Figure 6 . The two main limitations of this study are the lack of the assessment of the intra-and inter-operator 351 variability in pneumonia staging using LUS imaging and the unavailability of clinical data to define severity. 352

Regarding the lack of variability assessment, with this initial settlement and validation of the software 353 module, the variability in pneumonia staging was not considered crucial, also because there was no the actual 354 possibility of re-scanning the patients due to the emergency context and to the use of some cases obtained 355 from online databases: variability will be investigated with subsequent dedicated studies, involving smaller 356 number of patients and just focused on the assessment of repeatability and reproducibility. This aspect is 357 also connected with the involvement of different operators. On one side, this might be a disadvantage, since 358 the evaluation of the performance might have been influenced by the contribution of the inter-operator 359 variability, but on the other side the real-life use of LUS should be considered: though the use of this 360 technology is simple and requires a relatively short training period [28], the employment of LUS has only 361 recently spread in clinical practice. For this reason, the majority of the operators have a short experience. It 362 would be of interest the assessment of the performance by varying the operator's experience, also to assess 363 whether the guided acquisition and the automatic analysis offered by the software would be an aid in the 364 reduction of the operator-related variability. In this context, the use of an expert operator analysis as a gold 365 standard reference could be also considered a limitation of the study, although this is a very common 366 approach in studies aimed to evaluate the accuracy of automatic or semi-automatic algorithms for ultrasound 367 image processing for various purposes. 368

Regarding the absence of clinical data to define disease severity, actually, values such as oxygen saturation, 369 oxygen support, PaO2/FIO2 ratio etc., were not available because the considered cases derived either from 370 scanning performed in the emergency context or from online databases. However, the key object of the 371 present study was to compare the automatic LUS score assigned by the algorithm with the score assigned by 372 an expert operator based on the echographic image analysis only, and this should not be influenced by the 373 mentioned clinical data. 374

Moreover, this study is a snapshot of a short-period activity during the SARS-CoV-2 pandemic, therefore 375 characterized by the high prevalence of the COVID-19 pneumonia. The use of this technology in a standard 376 clinical scenario should be investigated in subsequent studies. 377

Finally, the monitoring of the enrolled patients is missing in this report. Indeed, the addition of further 378 analysis for the monitoring would have made it incompatible with the overloaded clinical routine, but it will 379 be planned in further studies dedicated to the monitoring of pneumonia disease evolution. 380

As yet, there are no devices that can automatically evaluate ultrasonographic data derived from lung 381 investigations, unless based on artificial intelligence approaches [29, 30] . Nonetheless, important studies 382 have been conducted before the onset of the SARS-CoV-2 pandemic, on the development of automatic or 383 semi-automatic algorithms based on LUS image processing, but they are not commercially available so far. 384

Interesting approaches for the automatic identification and quantitative assessment of B-lines in patients 385 with pulmonary edema or acute respiratory distress have been recently proposed [10, 31] , showing that the 386 implementation of quantitative LUS through computer-aided scoring had potential benefits in terms of faster 387 data analysis and applicability to large datasets at no additional cost. Interestingly, the method proposed in 388 the present study is similar, though it integrates also the fully automatic analysis of ultrasonographic data 389 and works in real-time. In a study by Corradi et al. [11] , the diagnostic performance of a method for the 390 quantitative analysis of LUS was compared with chest X-ray and visual assessment of LUS for the detection 391 of pneumonia, using CT as the gold standard. Quantitative LUS showed greater sensitivity (93%), specificity 392 (95%) and diagnostic accuracy (94%) than chest X-ray and visual ultrasound or their combination in 393 diagnosing pneumonia. This is an evidence of how quantitative LUS might represent a valid support for the 394 physicians dedicated to the triage phase and committed to quickly referring the patient to the appropriate 395 care unit. 396

The methodology proposed in the present study allowed for the identification of patients suffering from 397 pneumonia with high accuracy. The implemented method integrated the known advantages of the generic 398 LUS (such as portability, non-invasiveness and real-time information), which allow for the use at bedside also 399 in intensive care units, first aid departments and Special Continuity Care Units that provide home care for 400 COVID-19 patients, with the automatic approach that increased the objectivity and gave a quantitative 401 indicator of the pneumonia staging, with potentially important implications in terms of reduction of operator-402 related variability and usability regardless of the operator's experience. 403

This new LUS-based technology, described and preliminarily validated in this study, showed a good capability 405 of diagnosing and staging pneumonia. The reported results unveil also the potential of the new LUS-based 406 technology to be used to monitor pneumonia evolution in a personalized way (i.e., by repeating the exam

Effectiveness of lung ultrasonography for diagnosis of pneumonia in 422 adults: a systematic review and meta-analysis

Lung Ultrasound for Diagnosing Patients with Severe Dyspnea and 425

Lung Ultrasound Imaging, a Technical Review

Lung ultrasound in the critically ill

Lung ultrasound for the diagnosis of pneumonia in adults: A 430 meta-analysis. Medicine (Baltimore)

Thoracic ultrasonography: a narrative review

Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases

The comet-tail artifact. An ultrasound sign of 438 alveolar-interstitial syndrome

A lung ultrasound sign allowing bedside distinction between pulmonary edema and 441 COPD: the comet-tail artifact

Quantitative lung ultrasonography: a putative new algorithm for automatic detection and quantification of B-444 lines. Crit Care

Quantitative analysis of lung ultrasonography for the detection of community-acquired pneumonia: a pilot study

Lung ultrasound in the ICU: from diagnostic instrument to 451 respiratory monitoring tool

Lung Ultrasound May Support Diagnosis and Monitoring of COVID-19 Pneumonia

Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to 458 chest CT scan

Lung ultrasound for the diagnosis of SARS-CoV-2 pneumonia in the 461 Emergency Department

Open 464 questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of 465 worldwide international experts

Lung ultrasound in the diagnosis and monitoring of community acquired pneumonia in children

Henry TS; six signatories. A role for CT in COVID-19? What data 471 really tell us so far

Why, when, and how to use 474 lung ultrasound during the COVID-19 pandemic: enthusiasm and caution

Population-based age-stratified seroepidemiological investigation protocol 477 for COVID-19 virus infection

Proposal for International Standardization of the Use of Lung 481

Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method

Lung Ultrasound for COVID-19 Patchy Pneumonia : Extended or Limited Evaluations?

Receiver-operating characteristic curves and likelihood ratios: improvements over 487 traditional methods for the evaluation and application of veterinary clinical pathology tests

Basic principles of ROC analysis

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical 492 medicine

Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation 494 for sensitivity and specificity

Lung ultrasound training: a systematic 497 review of published literature in clinical lung ultrasound training

The future ahead and the lessons learned from COVID-19

Automated 502

Lung Ultrasound B-Line Assessment Using a Deep Learning Algorithm

Deep Learning for Classification and Localization of COVID-19 Markers in Point-of-Care Lung 507

Ultrasound

Automatic Detection of B-Lines in In Vivo 510

Lung Ultrasound

Rocco Morello 1 , PhD, Ernesto Casciaro 1 , PhD, Stefania Ianniello 2 , MD

2 -Diagnostic Imaging Unit, National Institute for Infectious Diseases

Pneumology Unit 2, Vito Fazzi Hospital

4 -Department of clinical-surgical, diagnostic and pediatric sciences, Unit of anesthesia and intensive care

5 -Anesthesia and Intensive Care

with the frequency deemed as appropriate by the physician). Moreover, in addition to a 5-stage pneumonia 408 scoring given by the Lung Staging parameter, the statistical probability of being infected by SARS-CoV-2 was 409 also expressed through the COVID Index, thus allowing the clinical staff to activate the most adequate clinical 410 path. 411This device might represent a significant decision support tool for both experienced and less experienced 412 staff (in particular for personnel in training), due to the simplicity of its use, with a user-guided acquisition 413 and a fully automatic real-time analysis. Indeed, it does not require the visual analysis of the acquired images, 414 though it is given the operator the possibility to accept or to intervene to modify the automatically obtained 415 result. The adoption of this approach within the triage and intensive care areas, as well as in the ambulance 416 or at patient's home, might have important implications both at the population level, since it would allow for 417 mass screening and widespread prevention (particularly for the more fragile population, such as the elderly 418 and patients with previous comorbidities or other risk factors), and at healthcare system level, offering a 419 rapid and cost-effective identification of any-aetiology pneumonia in a simple and objective way. 420